180 Life Sciences Files 8-K Report
Ticker: FRMM · Form: 8-K · Filed: Jul 2, 2024 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 8-K |
| Filed Date | Jul 2, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, filing, financials
TL;DR
180 Life Sciences filed an 8-K, mostly boilerplate financial stuff, no major news yet.
AI Summary
On July 2, 2024, 180 Life Sciences Corp. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or transactions detailed in the provided text. The company, formerly known as KBL Merger Corp. IV, is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This 8-K filing indicates that 180 Life Sciences Corp. is fulfilling its reporting obligations, though it does not disclose any new material events at this time.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain information that suggests an immediate change in risk for the company.
Key Players & Entities
- 180 Life Sciences Corp. (company) — Registrant
- KBL Merger Corp. IV (company) — Former company name
- July 2, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Palo Alto, CA (location) — Business address
FAQ
What is the primary purpose of this 8-K filing for 180 Life Sciences Corp.?
The filing is a Current Report on Form 8-K, primarily indicating the submission of financial statements and exhibits, and reporting on 'Other Events'.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated July 2, 2024.
What was the former name of 180 Life Sciences Corp.?
The former name of 180 Life Sciences Corp. was KBL Merger Corp. IV.
In which state is 180 Life Sciences Corp. incorporated?
180 Life Sciences Corp. is incorporated in Delaware.
What is the business address of 180 Life Sciences Corp.?
The business address is 3000 El Camino Real, Bldg. 4, Suite 200, Palo Alto, CA 94306.
Filing Stats: 488 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-07-02 08:00:24
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ATNF The NASDAQ Stock Mar
Filing Documents
- ea0208829-8k_180life.htm (8-K) — 29KB
- ea020882901ex99-1_180life.htm (EX-99.1) — 16KB
- 0001213900-24-058189.txt ( ) — 266KB
- atnf-20240702.xsd (EX-101.SCH) — 4KB
- atnf-20240702_def.xml (EX-101.DEF) — 26KB
- atnf-20240702_lab.xml (EX-101.LAB) — 36KB
- atnf-20240702_pre.xml (EX-101.PRE) — 25KB
- ea0208829-8k_180life_htm.xml (XML) — 6KB
01 Other Events
Item 8.01 Other Events. On July 2, 2024, 180 Life Sciences Corp. (the " Company ") filed a press release disclosing the fact that it has been provided an extension from a Hearing Panel of the Nasdaq Stock Market LLC (" Nasdaq ") to retain compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market. A copy of the press release is included herewith as Exhibit 99.1 and the information in the press release is incorporated by reference into this Item 8.01 in its entirety.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 99.1 Press Release, dated July 2, 2024 104 Cover Page Interactive Data File (embedded within Inline XBRL document). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 2, 2024 180 LIFE SCIENCES CORP. By: /s/ Blair Jordan Name: Blair Jordan Title: Interim Chief Executive Officer 2